510(k) K892856
K892856 is an FDA 510(k) premarket notification submitted by Acacia Laboratories, Inc. for the device "NEWMARK(TM) CORONARY ARTERY BYPASS GRAFT MARKERS". The FDA issued a decision of Substantially Equivalent on November 8, 1989. The device falls under product code KRI (Accessory Equipment, Cardiopulmonary Bypass), a Class I device regulated under 21 CFR 870.4200. Acacia Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 8, 1989
- Date Received
- April 18, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Accessory Equipment, Cardiopulmonary Bypass
- Device Class
- Class I
- Regulation Number
- 870.4200
- Review Panel
- CV
- Submission Type